Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q43719033)
Watch
English
The revitalization of thalidomide
scientific article published in July 2001
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
11521791
retrieved
26 November 2017
editorial
0 references
title
The revitalization of thalidomide
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11521791
retrieved
26 November 2017
main subject
thalidomide
0 references
author name string
D A Thomas
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11521791
retrieved
26 November 2017
H M Kantarjian
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11521791
retrieved
26 November 2017
language of work or name
English
1 reference
based on heuristic
inferred from title
publication date
1 July 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11521791
retrieved
26 November 2017
published in
Annals of Oncology
1 reference
stated in
Europe PubMed Central
PubMed ID
11521791
retrieved
26 November 2017
volume
12
1 reference
stated in
Europe PubMed Central
PubMed ID
11521791
retrieved
26 November 2017
page(s)
885-886
1 reference
stated in
Europe PubMed Central
PubMed ID
11521791
retrieved
26 November 2017
issue
7
1 reference
stated in
Europe PubMed Central
PubMed ID
11521791
retrieved
26 November 2017
cites work
Thalidomide increases both REM and stage 3-4 sleep in human adults: a preliminary study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Current role of thalidomide in cancer treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide is an inhibitor of angiogenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Factors promoting tumor angiogenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, Staphylococcal enterotoxin A, and purified protein derivative
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antitumor activity of thalidomide in refractory multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide and dexamethasone combination for refractory multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunomodulation by thalidomide and thalidomide analogues
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011123209816
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1023/A:1011123209816
1 reference
stated in
Europe PubMed Central
PubMed ID
11521791
retrieved
26 November 2017
Fatcat ID
release_4uikktp7lfenvppkctylj5ej6i
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/4uikktp7lfenvppkctylj5ej6i
retrieved
24 November 2022
based on heuristic
mapped directly with Wikidata item
PubMed ID
11521791
1 reference
stated in
Europe PubMed Central
PubMed ID
11521791
retrieved
26 November 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
